Brief: Adocia Initiates Phase 2 Clinical Trial For M1Pram

Adocia SA

10/03/2021 17:06

March 10 (Reuters) - Adocia SA  ADOC.PA :
    * ADOCIA INITIATES PHASE 2 CLINICAL TRIAL FOR M1PRAM IN
PATIENTS
WITH TYPE 1 DIABETES
    * ADOCIA INITIATES PHASE 2 CLINICAL TRIAL FOR M1PRAM IN
PATIENTS
WITH TYPE 1 DIABETES
    * STUDY HAS BEEN DESIGNED TO DEFINE PARAMETERS FOR UPCOMING
PHASE
3 TRIAL PLANNED FOR 2022
    * THIS STUDY FOLLOWS PROMISING RESULTS OF PROOF-OF-CONCEPT
PHASE 1
TRIAL ANNOUNCED ON SEPTEMBER 15, 2020

Source text for Eikon:  ID:nBw1GdHPfa 
Further company coverage:  ADOC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))